FR3104415B1 - Composition in the form of an aqueous suspension of propolis. - Google Patents

Composition in the form of an aqueous suspension of propolis. Download PDF

Info

Publication number
FR3104415B1
FR3104415B1 FR1914266A FR1914266A FR3104415B1 FR 3104415 B1 FR3104415 B1 FR 3104415B1 FR 1914266 A FR1914266 A FR 1914266A FR 1914266 A FR1914266 A FR 1914266A FR 3104415 B1 FR3104415 B1 FR 3104415B1
Authority
FR
France
Prior art keywords
composition
propolis
aqueous suspension
relates
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1914266A
Other languages
French (fr)
Other versions
FR3104415A1 (en
Inventor
Calderon Fernando Leal
Julien Monteil
Franck Duprat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Bordeaux
Institut Polytechnique de Bordeaux
Pollenergie SAS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Bordeaux
Institut Polytechnique de Bordeaux
Pollenergie SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Bordeaux, Institut Polytechnique de Bordeaux, Pollenergie SAS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1914266A priority Critical patent/FR3104415B1/en
Priority to PCT/EP2020/085829 priority patent/WO2021116443A1/en
Publication of FR3104415A1 publication Critical patent/FR3104415A1/en
Application granted granted Critical
Publication of FR3104415B1 publication Critical patent/FR3104415B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L’invention se rapporte à une composition comprenant au moins de la propolis et au moins un agent polymérique amphiphile d’origine naturelle, préférentiellement de la gomme arabique. L’invention concerne aussi le séchage de ladite composition pour obtenir une poudre redispersable dans l’eau.The invention relates to a composition comprising at least propolis and at least one amphiphilic polymeric agent of natural origin, preferably gum arabic. The invention also relates to the drying of said composition to obtain a powder redispersible in water.

FR1914266A 2019-12-12 2019-12-12 Composition in the form of an aqueous suspension of propolis. Active FR3104415B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1914266A FR3104415B1 (en) 2019-12-12 2019-12-12 Composition in the form of an aqueous suspension of propolis.
PCT/EP2020/085829 WO2021116443A1 (en) 2019-12-12 2020-12-11 Composition comprising propolis particles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1914266A FR3104415B1 (en) 2019-12-12 2019-12-12 Composition in the form of an aqueous suspension of propolis.
FR1914266 2019-12-12

Publications (2)

Publication Number Publication Date
FR3104415A1 FR3104415A1 (en) 2021-06-18
FR3104415B1 true FR3104415B1 (en) 2023-04-07

Family

ID=69700159

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1914266A Active FR3104415B1 (en) 2019-12-12 2019-12-12 Composition in the form of an aqueous suspension of propolis.

Country Status (2)

Country Link
FR (1) FR3104415B1 (en)
WO (1) WO2021116443A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987558B2 (en) * 1996-05-17 1999-12-06 埼玉養蜂株式会社 Water-dispersible propolis composition and method for producing the same
FR3006589B1 (en) * 2013-06-11 2015-09-11 Pollenergie USE OF PROPOLIS TO COMBAT PATHOLOGIES ASSOCIATED WITH OBESITY
FR3037799B1 (en) * 2015-06-29 2019-04-19 Sine Sileo HYDRODISPERSIBLE SOLID PARTICLES BASED ON PROPOLIS
RU2697839C1 (en) * 2018-11-14 2019-08-21 Александр Александрович Кролевец Method of producing nanocapsules of a dry extract of propolis

Also Published As

Publication number Publication date
WO2021116443A1 (en) 2021-06-17
FR3104415A1 (en) 2021-06-18

Similar Documents

Publication Publication Date Title
DK1993515T3 (en) Process for solubilizing, dispersing and stabilizing substances, products prepared according to the method and application of the same
BRPI0615292A8 (en) compositions and methods for preparing poorly soluble water drugs with increased stability
IL164222A0 (en) Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
FR3052071B1 (en) COMPOSITIONS IN THE FORM OF AQUEOUS INJECTABLE SOLUTION COMPRISING GLUCAGON AND A CO-POLYAMINOACID
ES2059950T3 (en) DOUBLE OIL-WATER-OIL COMPOSITION OF OIL OR EMULSIFIED FAT.
EP1101992A3 (en) Seal sleeve
MA51018A (en) COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINOACID
FR3030227B1 (en) EMULSIONS STABILIZED BY AMPHIPHILIC COMPOSITE PARTICLES
FR3104415B1 (en) Composition in the form of an aqueous suspension of propolis.
EP2806074A3 (en) Holding and dispensing device to be mounted in a toilet bowl and method of production of the dispensing device
DE602006020605D1 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
MA51600A (en) COMPOSITIONS IN THE FORM OF AN AQUEOUS SOLUTION FOR INJECTION CONSISTING OF AMYLINE, AN AMYLINE RECEPTOR AGONIST OR ANALOGUE OF AMYLINE AND A CO-POLYAMINOACID
DE69906974D1 (en) THIXOTROPE FORMULATIONS FOR FILLING GELATINE CAPSULES
EP1722114A3 (en) Robust, lightweight connecting rod
MA51017A (en) COMPOSITIONS IN THE FORM OF AN AQUEOUS SOLUTION FOR INJECTION CONSISTING OF HUMAN GLUCAGON AND A CO-POLYAMINOACID
EP2251004A3 (en) Pharmaceutical or cosmetic composition and a mixed solubilisation method for the production thereof
BRPI0619282B8 (en) salt, and pharmaceutical composition
CA2377291A1 (en) Flying container
CL2018002949A1 (en) Compositions for oral care.
FR3018296B1 (en) MODULAR CLAMPING DEVICE FOR CANVAS FOR FALSE CEILING
AR118498A1 (en) LAUNDRY DETERGENT COMPOSITIONS
FR3046066B1 (en) COMPOSITION BASED ON SPICULISPORIC ACID
MX2020003932A (en) Method of use of personal cleansing compositions.
FR3033249B1 (en) AQUEOUS SOLAR COSMETIC COMPOSITION WITHOUT SURFACTANTS
FR3090327B1 (en) Gelled composition comprising two hydrophilic gelling agents and solid aggregates

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210618

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

RM Correction of a material error

Effective date: 20230203

PLFP Fee payment

Year of fee payment: 5